| pubmed-article:7673023 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:7673023 | lifeskim:mentions | umls-concept:C0013216 | lld:lifeskim |
| pubmed-article:7673023 | lifeskim:mentions | umls-concept:C0087111 | lld:lifeskim |
| pubmed-article:7673023 | lifeskim:mentions | umls-concept:C1522449 | lld:lifeskim |
| pubmed-article:7673023 | lifeskim:mentions | umls-concept:C0042679 | lld:lifeskim |
| pubmed-article:7673023 | lifeskim:mentions | umls-concept:C0079083 | lld:lifeskim |
| pubmed-article:7673023 | lifeskim:mentions | umls-concept:C1621958 | lld:lifeskim |
| pubmed-article:7673023 | lifeskim:mentions | umls-concept:C0016640 | lld:lifeskim |
| pubmed-article:7673023 | lifeskim:mentions | umls-concept:C0282460 | lld:lifeskim |
| pubmed-article:7673023 | lifeskim:mentions | umls-concept:C0332283 | lld:lifeskim |
| pubmed-article:7673023 | pubmed:issue | 2 | lld:pubmed |
| pubmed-article:7673023 | pubmed:dateCreated | 1995-10-19 | lld:pubmed |
| pubmed-article:7673023 | pubmed:abstractText | To conduct a Phase II one-arm study to evaluate the long-term efficacy and safety of accelerated fractionated radiotherapy combined with intravenous carboplatin for patients with previously untreated glioblastoma multiforme tumors. | lld:pubmed |
| pubmed-article:7673023 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7673023 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7673023 | pubmed:language | eng | lld:pubmed |
| pubmed-article:7673023 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7673023 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:7673023 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7673023 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7673023 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7673023 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7673023 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:7673023 | pubmed:month | Sep | lld:pubmed |
| pubmed-article:7673023 | pubmed:issn | 0360-3016 | lld:pubmed |
| pubmed-article:7673023 | pubmed:author | pubmed-author:RodriguezLL | lld:pubmed |
| pubmed-article:7673023 | pubmed:author | pubmed-author:LevinV AVA | lld:pubmed |
| pubmed-article:7673023 | pubmed:author | pubmed-author:BrunetDD | lld:pubmed |
| pubmed-article:7673023 | pubmed:author | pubmed-author:LeedsNN | lld:pubmed |
| pubmed-article:7673023 | pubmed:author | pubmed-author:YungW KWK | lld:pubmed |
| pubmed-article:7673023 | pubmed:author | pubmed-author:SawayaRR | lld:pubmed |
| pubmed-article:7673023 | pubmed:author | pubmed-author:WooSS | lld:pubmed |
| pubmed-article:7673023 | pubmed:author | pubmed-author:KyritsisA PAP | lld:pubmed |
| pubmed-article:7673023 | pubmed:author | pubmed-author:MaorM HMH | lld:pubmed |
| pubmed-article:7673023 | pubmed:author | pubmed-author:ThallP FPF | lld:pubmed |
| pubmed-article:7673023 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:7673023 | pubmed:day | 30 | lld:pubmed |
| pubmed-article:7673023 | pubmed:volume | 33 | lld:pubmed |
| pubmed-article:7673023 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:7673023 | pubmed:authorsComplete | N | lld:pubmed |
| pubmed-article:7673023 | pubmed:pagination | 357-64 | lld:pubmed |
| pubmed-article:7673023 | pubmed:dateRevised | 2007-11-14 | lld:pubmed |
| pubmed-article:7673023 | pubmed:meshHeading | pubmed-meshheading:7673023-... | lld:pubmed |
| pubmed-article:7673023 | pubmed:meshHeading | pubmed-meshheading:7673023-... | lld:pubmed |
| pubmed-article:7673023 | pubmed:meshHeading | pubmed-meshheading:7673023-... | lld:pubmed |
| pubmed-article:7673023 | pubmed:meshHeading | pubmed-meshheading:7673023-... | lld:pubmed |
| pubmed-article:7673023 | pubmed:meshHeading | pubmed-meshheading:7673023-... | lld:pubmed |
| pubmed-article:7673023 | pubmed:meshHeading | pubmed-meshheading:7673023-... | lld:pubmed |
| pubmed-article:7673023 | pubmed:meshHeading | pubmed-meshheading:7673023-... | lld:pubmed |
| pubmed-article:7673023 | pubmed:meshHeading | pubmed-meshheading:7673023-... | lld:pubmed |
| pubmed-article:7673023 | pubmed:meshHeading | pubmed-meshheading:7673023-... | lld:pubmed |
| pubmed-article:7673023 | pubmed:meshHeading | pubmed-meshheading:7673023-... | lld:pubmed |
| pubmed-article:7673023 | pubmed:meshHeading | pubmed-meshheading:7673023-... | lld:pubmed |
| pubmed-article:7673023 | pubmed:meshHeading | pubmed-meshheading:7673023-... | lld:pubmed |
| pubmed-article:7673023 | pubmed:meshHeading | pubmed-meshheading:7673023-... | lld:pubmed |
| pubmed-article:7673023 | pubmed:meshHeading | pubmed-meshheading:7673023-... | lld:pubmed |
| pubmed-article:7673023 | pubmed:meshHeading | pubmed-meshheading:7673023-... | lld:pubmed |
| pubmed-article:7673023 | pubmed:meshHeading | pubmed-meshheading:7673023-... | lld:pubmed |
| pubmed-article:7673023 | pubmed:meshHeading | pubmed-meshheading:7673023-... | lld:pubmed |
| pubmed-article:7673023 | pubmed:year | 1995 | lld:pubmed |
| pubmed-article:7673023 | pubmed:articleTitle | Phase II study of accelerated fractionation radiation therapy with carboplatin followed by vincristine chemotherapy for the treatment of glioblastoma multiforme. | lld:pubmed |
| pubmed-article:7673023 | pubmed:affiliation | Department of Neuro-Oncology, University of Texas M. D. Anderson Cancer Center, Houston 77030, USA. | lld:pubmed |
| pubmed-article:7673023 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:7673023 | pubmed:publicationType | Clinical Trial | lld:pubmed |
| pubmed-article:7673023 | pubmed:publicationType | Research Support, U.S. Gov't, P.H.S. | lld:pubmed |
| pubmed-article:7673023 | pubmed:publicationType | Multicenter Study | lld:pubmed |
| pubmed-article:7673023 | pubmed:publicationType | Clinical Trial, Phase II | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:7673023 | lld:pubmed |
